How These Two Leading Weight Management Treatments Compare
How Wegovy Works Differently From Mounjaro: The Science Behind Each Treatment
Understanding how Wegovy works compared to Mounjaro begins with their distinct mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormone to reduce appetite and promote satiety after smaller meals. This single-pathway approach has been refined through extensive clinical development, targeting the brain's appetite centres to help patients feel fuller for longer periods.
Mounjaro operates through a dual mechanism, combining GLP-1 receptor activation with glucose-dependent insulinotropic polypeptide (GIP) receptor stimulation. This tirzepatide-based approach may offer enhanced metabolic effects by working on two hormone pathways simultaneously. Both treatments require weekly injections and must be used alongside a reduced-calorie diet and increased physical activity, but their different mechanisms mean your prescriber can select the most appropriate option based on your individual clinical profile and treatment goals.
Wegovy vs Mounjaro Pricing: Complete UK Cost Comparison
EverydayMeds offers transparent pricing for both treatments, allowing genuine comparison without availability restrictions. Wegovy follows a 5-dose escalation schedule starting with 0.25mg at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to maintenance dose 2.4mg (£209.99). New customers apply code FIRST40 at checkout to reach these prices, whilst returning customers use code DOSE25.
Mounjaro requires 6 dose escalations from 2.5mg through to 15mg maintenance, with pricing reflecting the higher dose strengths and extended titration period. Our bundle options provide convenience for both treatments – Wegovy's Intro Trio (0.25mg, 0.5mg, 1mg) costs £299.99, whilst our Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99. Having both options available means your choice depends purely on clinical suitability rather than pharmacy stock limitations.
How Wegovy Works: Clinical Evidence From STEP Trials
The STEP clinical trial programme demonstrates how Wegovy works in real-world conditions. In the landmark STEP 1 trial (Wilding et al., NEJM, 2021), patients taking Wegovy alongside a reduced-calorie diet and increased physical activity achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo. STEP 5 data shows this effect can be sustained at approximately 15.2% after two years of continuous treatment.
The SELECT cardiovascular outcomes trial revealed how Wegovy works beyond weight management, demonstrating a 20% reduction in major cardiovascular events (hazard ratio 0.80) in adults with established cardiovascular disease. This evidence supported NICE recommendation TA875 for Wegovy with specialist weight management support, establishing its role in comprehensive obesity treatment protocols.
Understanding How Wegovy Works: The GLP-1 Mechanism Explained
Wegovy's semaglutide active ingredient works by binding to GLP-1 receptors in multiple body tissues, particularly in the brain regions controlling appetite and food intake. When you inject Wegovy weekly, it mimics the natural GLP-1 hormone that's normally released after eating, but provides sustained activation throughout the week. This prolonged receptor stimulation helps reduce hunger signals, increases feelings of fullness after smaller portions, and may diminish food cravings between meals. The treatment also slows gastric emptying, meaning food stays in your stomach longer, contributing to extended satiety. Additionally, GLP-1 receptor activation supports healthy blood glucose regulation by enhancing insulin sensitivity, though Wegovy is specifically licensed for weight management rather than diabetes treatment.
How Wegovy Works Through Our Ordering Process
Accessing Wegovy through EverydayMeds begins with our 3-minute online clinical assessment, designed to evaluate your suitability for either Wegovy or Mounjaro based on BMI, medical history, and treatment goals. Our UK-registered prescribers (GPhC #9012878) review your assessment within 3 working days, or 24 hours with express service, ensuring appropriate treatment selection. Once approved, your Wegovy pens are dispatched via temperature-controlled cold-chain delivery, arriving next working day in pharmaceutical-grade packaging. Our prescribers can recommend starting with single pens to assess tolerance, or suggest appropriate bundles like the Intro Duo (0.25mg & 0.5mg) for £169.99 to cover your initial 8 weeks. This streamlined process ensures you understand exactly how Wegovy works before beginning treatment, with ongoing clinical support throughout your journey.
How Wegovy Works in Practice: Storage and Administration
Understanding how Wegovy works includes mastering the practical aspects that differentiate it from Mounjaro. Wegovy pens require refrigerated storage at 2-8°C before first use, but offer superior travel flexibility with 6 weeks room temperature tolerance below 30°C once removed from the fridge – significantly longer than Mounjaro's 21-day limit. The FlexTouch pen system delivers your weekly dose through a simple subcutaneous injection, typically in the thigh, abdomen, or upper arm. Dose escalation follows a mandatory 4-week schedule at each strength, allowing your body to adapt gradually whilst minimising potential side effects. The 5-dose progression from 0.25mg to 2.4mg maintenance ensures optimal tolerance, and this structured approach cannot be accelerated regardless of initial response. Weekly injection timing should remain consistent, though you can adjust by up to 3 days if needed for convenience.
How Wegovy Works vs Mounjaro: Key Practical Differences
The practical differences in how Wegovy works compared to Mounjaro extend beyond their receptor mechanisms. Wegovy's 5-dose escalation schedule typically reaches maintenance dosing at week 17, whilst Mounjaro's 6-stage progression may extend this timeline further. Storage requirements favour Wegovy for frequent travellers, with that crucial 6-week room temperature advantage over Mounjaro's more restrictive 21-day limit.
Injection volumes differ significantly – Wegovy delivers smaller volumes per injection due to its concentrated formulation, whilst Mounjaro requires larger volumes at higher dose strengths. Both treatments use similar injection techniques, but the pen designs and dose selection mechanisms vary between manufacturers. Your prescriber will consider these practical factors alongside clinical effectiveness when recommending between treatments, ensuring your choice aligns with your lifestyle and treatment preferences.
Start Your Wegovy vs Mounjaro Comparison Today
Ready to discover how Wegovy works for your weight management goals? EverydayMeds' unique position offering both treatments means your prescriber can provide unbiased clinical guidance without availability constraints. New customers use code FIRST40 at checkout, whilst returning customers apply DOSE25 to access our competitive pricing. Our clinical assessment evaluates your suitability for both options, ensuring you receive the most appropriate treatment based on medical evidence rather than limited pharmacy stock. Complete your assessment today and join thousands of patients who've discovered how Wegovy works as part of their comprehensive weight management journey. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment with our UK-registered prescribers.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
